Achieve Life Sciences (ACHV) Exchange Rate Effect (2010 - 2025)
Achieve Life Sciences (ACHV) recorded quarterly Exchange Rate Effect of $4000.0 in Q4 2025, up 300.0% on a QoQ basis from -$2000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Exchange Rate Effect (2010 - 2025) Analysis & Trends
Achieve Life Sciences has disclosed Exchange Rate Effect across 13 years of filings, most recently posting $4000.0 for Q4 2025.
- Quarterly Exchange Rate Effect changed N/A year-over-year to $4000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3000.0 (changed N/A YoY) and the FY2025 annual result came in at $3000.0, changed N/A from the prior year.
- Exchange Rate Effect grew to $4000.0 in Q4 2025, from -$2000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $4000.0 in Q4 2022 and troughed at -$3000.0 in Q3 2021.
- A 4-year average of $428.57 and a median of -$1000.0 in 2022 frame the typical range for Exchange Rate Effect.
- Biggest YoY gain for Exchange Rate Effect was 0.0% in 2023; the steepest drop was 0.0% in 2023.
- Tracing ACHV's Exchange Rate Effect over 4 years: stood at -$3000.0 in 2021, then surged by 233.33% to $4000.0 in 2022, then plunged by 50.0% to $2000.0 in 2023, then jumped by 100.0% to $4000.0 in 2025.
- Business Quant data shows ACHV's Exchange Rate Effect at $4000.0 in Q4 2025, -$2000.0 in Q1 2025, and $2000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Sep 30, 2021 | -3,000.00 |
| Sep 30, 2021 | -3,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Sep 30, 2019 | 1,000.00 |
| Sep 30, 2019 | 1,000.00 |